Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-28 @ 1:06 AM
Study NCT ID:
NCT07022457
Status:
RECRUITING
Last Update Posted:
2025-08-03
First Post:
2025-05-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Sponsor:
Pierre Fabre Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-01-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-13
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-16
First Submit QC Date:
None
Study First Post Date:
2025-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-30
Last Update Post Date:
2025-08-03
Last Update Post Date Type:
ACTUAL